Exclusive: EPO under fire from staff reps amid IPQC criticisms

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Exclusive: EPO under fire from staff reps amid IPQC criticisms

EPO

The EPO has offered another meeting with the Industry Patent Quality Charter, while a committee representing EPO staff endorsed the group’s criticisms

An EPO staff committee has backed a group of in-house counsel’s claims that quality standards at the office are in decline, Managing IP can confirm.

Meanwhile, it is understood the EPO has offered a follow-up meeting with the counsel, who are members of the Industry Patent Quality Charter (IPQC).

The IPQC and EPO met initially on February 3 to discuss the group’s claims that the EPO no longer prioritises full search and examination over speedy patent grants.

A date for a second meeting has not been set at the time of publication.

The in-house group, which includes counsel from companies such as Siemens, Bayer, Nokia, Volvo and Ericsson, then sent a letter on February 8 to request joint working groups to monitor specific quality issues.

The central staff committee (CSC), which represents EPO staff in consultative meetings with management, has since published an internal bulletin backing the IPQC’s criticisms.

In the document, published on February 24 and seen by Managing IP, the CSC said the EPO management has focused on productivity gains over substantive quality for the past decade.

Staff are under pressure to grant as many patents as possible, with substantive quality of search and examination procedures “being secondary to productivity and timeliness”, the bulletin said.

EPO staff members have repeatedly raised concerns over the quality of search and examination but have been rebuffed by management.

“Management should take the [IPQC] criticism very seriously,” the document stated.

“Hopefully the IPQC initiative will trigger an adequate reaction that goes beyond denial, window dressing and continuing to hope that progress in IT tools will solve the problems.”

EPO staff would be “perfectly capable” of carrying out search and examination of the highest quality if given enough time, the document added.

The CSC further urged the EPO to hire more staff and replace all examiners after they have retired.

Members of the CSC have filed complaints against the EPO at the International Labour Organization (ILO) in recent years.

In November 2022, the ILO dismissed a complaint from CSC members over the EPO's refusal to allow the committee to publish a document criticising EPO HR policies on the office intranet.

The EPO declined to comment on this article.

more from across site and SHARED ros bottom lb

More from across our site

The team, comprising two partners and one senior consultant, plans to offer “highly differentiated” services to clients
HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Gift this article